Fusobacteriumnucleatum: Pathophysiological and Clinical Involvement in Inflammatory Bowel Diseases, Colorectal Cancer and Cardiovascular Diseases
Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano Berretta(University of Messina), Giuliana Ciappina(University of Ferrara), Antonio Bottari(University of Messina), Nicola Maurea(Cancer Institute (WIA)), Francesco Fiorica(University of Verona), Carlotta Giorgi(University of Ferrara), Pietro Forte(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Giordana Di Mauro(University of Messina), Luigi Colarusso(University of Messina)
Cited by 5
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development
|Cell Reports|2016|153
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108
Resveratrol in Cancer Patients: From Bench to Bedside
|International Journal of Molecular Sciences|2020|105